Education
About Us
Working with TipRanks
Follow Us
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged (TSE:ABT)
TSX:ABT
Total Valuation
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged has a market cap or net worth of C$269.84B. The enterprise value is $0.00.
Market CapC$269.84B
Enterprise Value$0.00
Share Statistics
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged has 1,738,872,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,738,872,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged’s return on equity (ROE) is -0.25 and return on invested capital (ROIC) is 23.96%.
Return on Equity (ROE)-0.25
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)23.96%
Return on Capital Employed (ROCE)0.56
Revenue Per Employee10.00T>
Profits Per Employee10.00T>
Employee Count―
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged is 3.9. Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged’s PEG ratio is 0.00.
PE Ratio3.9
PS Ratio0.00
PB Ratio0.00
Price to Fair Value―
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.00
Income Statement
In the last 12 months, Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged had revenue of 104.67M and earned 10.63M in profits. Earnings per share was 0.24.
Revenue104.67M
Gross Profit92.04M
Operating Income15.27M
Pretax Income15.24M
Net Income10.63M
EBITDA21.18M
Earnings Per Share (EPS)0.24
Cash Flow
In the last 12 months, operating cash flow was 32.19M and capital expenditures -3.15M, giving a free cash flow of 29.03M billion.
Operating Cash Flow32.19M
Free Cash Flow29.03M
Free Cash Flow per Share0.02
Dividends & Yields
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.10
52-Week Price Change-9.36%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged upcoming earnings date is Apr 22, 2026, Before Open (Confirmed).
Last Earnings DateJan 28, 2026
Next Earnings DateApr 22, 2026
Ex-Dividend Date―
Financial Position
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged as a current ratio of ―, with Debt / Equity ratio of -23.54%
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA-0.93
Interest Coverage Ratio―
Taxes
In the past 12 months, Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged has paid 4.61M in taxes.
Income Tax4.61M
Effective Tax Rate―
Enterprise Valuation
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 0.00.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged has C$58.24M in cash and marketable securities with C$9.83M in debt, giving a net cash position of C$48.41M billion.
Cash & Marketable SecuritiesC$58.24M
Total DebtC$9.83M
Net CashC$48.41M
Net Cash Per ShareC$0.03
Tangible Book Value Per Share―
Margins
Gross margin is 87.94%, with operating margin of ―, and net profit margin of ―.
Gross Margin87.94%
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―